HYDUR LIMITED

Company number 13100752 ·

Active

This analysis was written by an AI from the company's public filings. It may contain errors or omissions and is not financial or professional advice.

HYDUR LIMITED - Analysis Report

Company Number: 13100752

Analysis Date: 2025-07-20 13:03 UTC

Financial Health Assessment Report for HYDUR LIMITED


1. Financial Health Score: D

Explanation:
HYDUR LIMITED exhibits clear symptoms of financial distress as evidenced by its negative net assets and escalating current liabilities. Although there is recent improvement, the overall financial health is fragile due to ongoing liquidity issues and significant creditor pressure. The score reflects urgent attention required to stabilize the business.


2. Key Vital Signs

Metric 2023 (£) 2022 (£) Interpretation
Fixed Assets 101,049 1,094 Significant investment in long-term assets in 2023, a positive sign of capital commitment.
Current Assets 50,844 40,145 Current assets have grown, indicating improved short-term resource availability.
Current Liabilities 193,995 71,928 Very high current liabilities, nearly 4.9x current assets in 2023; indicates liquidity strain.
Net Current Assets (Working Capital) -143,151 -31,783 Negative working capital worsened in 2023, showing inability to cover short-term debts.
Creditors Due After 1 Year 112,670 0 New long-term liabilities introduced in 2023, possibly to ease immediate cash flow pressure.
Net Assets (Shareholders’ Funds) -154,772 -30,689 Deeply negative equity position signals ongoing losses or accumulated deficits.
Average Employees 4 2 Workforce doubled, which may increase operational costs but also capacity.

Interpretation:
The company is showing “symptoms of distress” primarily related to liquidity and solvency. The sharp rise in current liabilities far outpaces current assets, indicating a “cash flow blockage” that could impair day-to-day operations. Negative net assets reflect accumulated losses or financing through debt rather than equity, weakening the company’s financial “immune system.” However, fixed asset growth and increased staffing suggest attempts at operational scaling or investment.


3. Diagnosis

HYDUR LIMITED is currently in a precarious financial condition. The company’s balance sheet shows significant erosion of net assets, moving from a negative position in prior years to a deeper deficit in 2023. The drastic increase in current liabilities relative to current assets signals a critical liquidity imbalance — the business does not have enough readily available assets to pay off short-term debts, akin to a patient with dangerously low blood pressure that threatens organ function.

The introduction of long-term creditors in 2023 may indicate restructuring efforts to convert some short-term debt into longer-term obligations, a common stabilizing tactic to relieve immediate cash flow pressure. However, the overall negative net asset position is a “chronic illness” marker that suggests the company has been operating at a loss or heavily leveraged.

The doubling of employee numbers implies increased operational activity or growth ambitions, but this also raises fixed costs, which could exacerbate financial strain if not matched by revenue growth.


4. Recommendations

To improve financial wellness, HYDUR LIMITED should consider the following actions:

  • Urgently Improve Liquidity:
    Focus on increasing cash inflows and managing payables. Accelerate receivables collection, review credit terms, and negotiate longer payment terms with suppliers to ease the working capital crunch.

  • Restructure Debt:
    Continue converting short-term liabilities into longer-term debt to spread out repayment obligations and reduce immediate creditor pressure. Explore refinancing options with lenders.

  • Cost Control:
    Assess the increased headcount and operational expenses to ensure they are aligned with revenue generation. Implement tight cost management to prevent further erosion of financial reserves.

  • Equity Injection:
    Given the negative net asset position, a capital injection from shareholders or new investors may be necessary to restore the company’s financial stability and improve solvency ratios.

  • Regular Financial Monitoring:
    Establish monthly cash flow forecasting and financial review processes to detect “early warning signs” and enable timely corrective measures.

  • Strategic Business Review:
    Reassess the business model and market positioning, ensuring that investments in fixed assets and staffing are generating adequate returns.


Perspective: Financial Health Diagnostician · Model: gpt-4.1-mini · Generated 20 July 2025

Sign in to generate a free AI analysis of this company — no password needed, just an email link.